Skip to main content

Day: November 4, 2024

Cohen & Company Reports Third Quarter 2024 Financial Results

Board Declares Quarterly Dividend of $0.25 per Share PHILADELPHIA and NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) — Cohen & Company Inc. (NYSE American: COHN), a financial services firm specializing in an expanding range of capital markets and asset management services, today reported financial results for its third quarter ended September 30, 2024. Summary Operating Results     Three Months Ended   Nine Months Ended ($ in thousands) 9/30/24   6/30/24   9/30/23   9/30/24   9/30/23                     Net trading $ 8,816     $ 8,798     $ 7,491     $ 27,462     $ 23,117   Asset management   2,147       2,078       1,788       6,942       5,418   New issue and advisory   22,459       6,500       7,247       53,347       9,542   Principal transactions and other revenue   (1,727 )     (6,578 )     595       (26,694 )     10,440   Total...

Continue reading

Janover Enters Licensing Agreement with Leading Commercial Real Estate Services Firm to Provide AI Client Engagement Tools

BOCA RATON, FL, Nov. 04, 2024 (GLOBE NEWSWIRE) — Janover Inc. (Nasdaq: JNVR) (“Janover” or the “Company”), an AI-enabled platform connecting the commercial real estate industry, is pleased to announce a licensing agreement with one of the nation’s top 20 publicly traded commercial real estate professional services firms. Through this partnership, Janover’s AI tools will be deployed to enhance client engagement and streamline communication, setting a new standard for service and efficiency in commercial real estate. This agreement marks a milestone in Janover’s transition to subscription revenue including licensing its highly customized conversational artificial intelligence. “This deployment with a major industry leader underscores the real-world demand for our AI as the battle to deliver better services and data more efficiently...

Continue reading

Vital Battery Metals Completes Inaugural Drill Program and Intersects Copper Mineralization at Flagship Sting Copper Project

VANCOUVER, British Columbia, Nov. 04, 2024 (GLOBE NEWSWIRE) — Vital Battery Metals Inc. (“Vital” or the “Company”) (CSE: VBAM | OTC: VBAMF | FRA: C0O), is pleased to announce the completion of its fall 2024 drilling campaign at the Company’s Sting Copper Project (“Project” or “Sting”), located in western Newfoundland, Canada. Over the course of the program, a total of 912 meters have been drilled in 5 drill holes (Figs. 1-2, Table 1), that all successfully intersected zones with chalcopyrite and pyrite mineralization* ranging in form from disseminations and stringers to semi-massive zones associated with veining or regional lithological contacts and faulting. Figure 1: Sting Copper Project Location Map Figure 2: Sting Copper Project drilling overview. Soil samples shown include additional anomalous samples collected during the...

Continue reading

Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference

HAYWARD, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference (“ddRNAi”) platform, today announces CEO Jerel A. Banks, M.D., Ph.D. will be participating in the Guggenheim Securities Healthcare Conference, taking place in Boston from November 11-13, 2024. Date: November 11, 2024Time: 2:30 PMFormat: Fireside Chat & 1×1 Meetings The Benitec presentation will also be available via live webcast here. Please contact your Guggenheim representative to schedule a 1×1 meeting with Benitec management. About Benitec Biopharma Inc.Benitec Biopharma Inc. (“Benitec” or the “Company”) is a clinical-stage...

Continue reading

InnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services

DENVER, Nov. 04, 2024 (GLOBE NEWSWIRE) — InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Michael Scarbrough as its new President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services, effective November 4th. Mr. Scarbrough joins InnovAge’s executive leadership team as Christine Bent steps down from the role of COO to explore new career opportunities. Scarbrough will also assume the role of President as the Company separates the positions of President and CEO to better enable execution of strategic priorities. The InnovAge team extends its gratitude to Ms. Bent for her exceptional service and numerous contributions, which...

Continue reading

CHAR Tech Announces Transition of the Altech Environmental Consulting Team and Assets to Cambium Inc. and Provides Update on North American Equipment Supply Strategy

TORONTO, Nov. 04, 2024 (GLOBE NEWSWIRE) — CHAR Technologies (“CHAR Tech” or the “Company”), a leader in sustainable energy solutions, is pleased to announce the transition of the Altech Environmental Consulting team and assets to Cambium Inc., a well-established provider of Environmental Consulting & Geotechnical Engineering services across Ontario. This transition aligns with CHAR’s ongoing strategy to focus on its renewable energy initiatives, allowing Altech’s team, projects, clients, and intellectual property to continue seamlessly under Cambium’s respected brand. This alignment supports CHAR Tech’s 2025 objectives to focus resources to the delivery of their build, own, and operate commercial woody biomass to renewable energy projects. Through this transition, Cambium Inc. will broaden its environmental consulting offerings,...

Continue reading

Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024

Management to Announce Earnings Results and hold a call at 8:30 am ET AUSTIN, Texas, Nov. 04, 2024 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that the Company will report its financial results for the three and nine months ended September 30, 2024, on Thursday, November 14, 2024. Management will also host a conference call at 8:30 am ET to discuss financial results and provide a corporate update. Details of the call are as follows: Conference Call & Webcast Details: Date: Thursday, November 14, 2024 Time: 8:30 am ET Toll Free: 877-545-0320 International: 973-528-0002 Access Code: 436613 Webcast: Registration Link A replay of the webcast...

Continue reading

HWH International Inc. Launches Hapi Marketplace, a Global B2C Marketplace Platform

Bethesda, MD, Nov. 04, 2024 (GLOBE NEWSWIRE) — HWH International Inc. (Nasdaq: HWH) is pleased to announce the launch of its proprietary business-to-consumer marketplace, Hapi Marketplace, which aims to offer a diversity of high-quality yet price competitive products. Hapi Marketplace features an extensive selection of over forty-seven product categories including wellness, elderly care, auto accessories and more. A special range of products are sourced by our team, allowing our customers to shop with confidence among a wide range of options. What sets Hapi Marketplace apart is its commitment to offering innovative products and customer care. The platform seeks to allow users to enjoy a smoother, more efficient shopping journey. This serves as a valuable offering for our members, enhancing our lifestyle membership. “Our mission...

Continue reading

CervoMed Announces Key Takeaways from Oral Presentations at the 17th Clinical Trials on Alzheimer’s Disease Conference (CTAD)

Data from the AscenD-LB Phase 2a trial in DLB confirm recent scientific literature indicating that plasma glial fibrillary acid protein (GFAP) is a robust measure of neurodegenerative disease activity in DLB Neflamapimod treatment previously led to significant reduction in plasma GFAP levels (p=0.015 versus placebo) and these reductions were associated with an improvement in clinical outcomes The RewinD-LB Phase 2b clinical study successfully enrolled a DLB patient population that is optimized to show the treatment effect of neflamapimod when topline data are reported in December BOSTON, Nov. 04, 2024 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for age-related neurologic disorders, today announced key takeaways from two oral presentations characterizing the potential...

Continue reading

Alarum Achieves Significant Milestone; Fortune 200 Company Adopts its Website Unblocker Solution Following a Large-scale Evaluation

The customer, operating a multi-million cross-region network, is set to gain best-in-class data-driven capabilities, positioning itself to achieve sustained market leadership, by subscribing to both NetNut’s IPPN and Website Unblocker offerings TEL AVIV, Israel, Nov. 04, 2024 (GLOBE NEWSWIRE) — Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of internet access and web data collection solutions, today announced the expansion of its recently established relationship with a leading global Fortune 200 company, which has subscribed to the newly rolled-out Website Unblocker from NetNut, in addition to Internet Protocol Proxy Network (IPPN). The customer, operating a multi-million cross-region network, and a multi-billion US Dollar business, will enhance automation and customer spending while...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.